Indications for Bariatric Surgery
Bariatric surgery should be considered for individuals with a BMI ≥40 kg/m² or BMI ≥35 kg/m² with at least one obesity-related comorbidity, including type 2 diabetes, hypertension, obstructive sleep apnea, and non-alcoholic steatohepatitis. 1
Primary Indications Based on BMI
Bariatric surgery is indicated in the following scenarios:
- BMI ≥40 kg/m² (severe obesity) regardless of comorbidities 2, 1
- BMI ≥35 kg/m² with at least one obesity-related comorbidity 2, 1
- BMI ≥30 kg/m² with type 2 diabetes that could potentially go into remission (metabolic surgery) 2
- BMI >25 kg/m² for Asian populations due to different body composition and risk profiles 1
Qualifying Comorbidities
The presence of these obesity-related conditions strengthens the indication for bariatric surgery:
Metabolic conditions:
Cardiovascular conditions:
Respiratory conditions:
Other qualifying conditions:
- Polycystic ovary syndrome
- Pseudotumor cerebri
- Gastroesophageal reflux disease (GERD) 1
Special Considerations
Liver Disease
- Patients with compensated advanced chronic liver disease/compensated cirrhosis may be considered for bariatric surgery but require careful evaluation by a multidisciplinary team 1
- For patients with advanced fibrosis, improvement may be limited even with significant weight loss 1
- Bariatric surgery is not recommended as a primary surgery for NASH treatment 2
- The effectiveness and safety of bariatric surgery have not been established in patients with severe liver fibrosis or cirrhosis 2
Obesity with Decompensated Cirrhosis
- In patients with obesity with decompensated cirrhosis and BMI >35, bariatric surgery should be considered only at the time of liver transplantation or thereafter 2
- Sleeve gastrectomy is the technique of choice in selected patients with obesity with well-compensated cirrhosis or in the setting of liver transplantation 2
Benefits of Bariatric Surgery
Bariatric surgery provides significant benefits beyond weight loss:
- Substantial and sustained weight loss (approximately 25-30% at 1-2 years) 2, 3
- Improvement or resolution of obesity-related comorbidities:
- Reduced risk of malignant tumors, acute cerebrovascular events, and all-cause mortality 2
- Enhanced quality of life and increased longevity 2
Limitations and Risks
Despite its benefits, bariatric surgery has important limitations:
- 20-30% of patients may experience suboptimal clinical response (less than 20% total weight loss) or recurrent weight gain 2
- Potential risks include surgical complications and nutritional deficiencies 2
- Perioperative mortality rates range from 0.03% to 0.2% 3
- Long-term success depends on adherence to adjunctive interventions (nutrition therapy, physical activity, behavioral interventions) 2
Referral Process
Healthcare professionals should:
- Refer potentially eligible individuals to specialized centers with multidisciplinary teams capable of providing long-term follow-up and support 2
- Ensure patients undergo comprehensive preoperative evaluation, including assessment for type 2 diabetes and related complications 2
- Consider prediction scales to identify patients who may benefit most from metabolic and bariatric surgery 2
Conclusion
Bariatric surgery represents the most effective treatment for morbid obesity and its related comorbidities when non-surgical approaches have failed. The decision to proceed should be based on a careful assessment of the individual's BMI, comorbidities, and risk factors, with referral to specialized centers that can provide comprehensive multidisciplinary care and long-term follow-up.